UB-621

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameUB-621
Drug Alias NameUB-621
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionEnvelope glycoprotein D inhibitors
TargetsEnvelope glycoprotein D
Therapy Area/IndicationsHerpes SimplexHerpes Genitalis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesUnited Biopharma Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesUbp Greater China (Shanghai) Co LtdLianyao (Shanghai) Biological Technology Co LtdUnited Biopharma Inc
Inactive CompaniesN/A
Active IndicationsHerpes Genitalis
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A